Reata Pharmaceuticals
RETA
#2667
Rank
โ‚ฌ5.63 B
Marketcap
147,87ย โ‚ฌ
Share price
0.00%
Change (1 day)
317.23%
Change (1 year)

Revenue for Reata Pharmaceuticals (RETA)

Revenue in 2023 (TTM): โ‚ฌ21.57 Million

According to Reata Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ20.14 Million. In 2022 the company made a revenue of โ‚ฌ2.06 Million a decrease over the revenue in the year 2021 that were of โ‚ฌ10.14 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Reata Pharmaceuticals from 2015 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ21.57 M944.16%
2022 โ‚ฌ2.06 M-79.64%
2021 โ‚ฌ10.14 M38.36%
2020 โ‚ฌ7.33 M-69.02%
2019 โ‚ฌ23.67 M-49.47%
2018 โ‚ฌ46.84 M16.95%
2017 โ‚ฌ40.05 M-15.5%
2016 โ‚ฌ47.39 M2.99%
2015 โ‚ฌ46.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA